Gitaputri, Putu Aprilya
Unknown Affiliation

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

ANALISIS BIAYA DAN RASIONALITAS TERAPI PARU OBSTRUKTIF KRONIK DI RSU ANWAR MEDIKA SIDOARJO Lorensia, Amelia; Jalmav, Marthy Meliana; Yorasaki, Yosy Athaya; Saputra, I Nyoman Dodi; Gitaputri, Putu Aprilya
Jurnal Ilmiah Ibnu Sina (JIIS): Ilmu Farmasi dan Kesehatan Vol 9 No 1 (2024): JIIS
Publisher : Sekolah Tinggi Ilmu Kesehatan ISFI Banjarmasin

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36387/jiis.v9i1.1716

Abstract

COPD is the main cause of death, and is currently the fifth cause of death in the world. COPD patients experience decreased capacity for quality of life, physical disability and increased costs of living. In COPD patients, the use of more than one drug therapy and long-term use can carry the risk of drug-related problems. The aim is to analyze the costs and rationality of treating COPD exacerbations. The research design was retrospective to determine the costs and description of therapy for COPD patients at RSU Anwar Medika Sidoarjo. The variables are real costs, INA-CBGs rates, severity and treatment therapy. The research sample was inpatients with BPJS insurance who were diagnosed with COPD attacks at RSU Anwar Medika Sidoarjo for January 2019-December 2021, using the total sampling method. The data collection by observing research materials including medical records. Data analysis is descriptive for data analysis and the incidence of drug-related problems (MTO), and the Mann-Whitney test to determine significant differences between real hospital costs and INA CBG'S inpatient rates. The number of respondents involved was 81 people. The highest components of direct costs incurred by COPD patients during hospitalization are hotel room costs and the cost of consumable medical materials. There was no difference in real costs compared to the rates INA-CBG's (p=0.158). The total incidence of MTO that occurred was 83 cases consisting of inappropriate drug selection (19.27%), drugs without indications (66.26%), inappropriate drug combinations (4.81%), indications without drugs (2 .40%), too many drugs for  same indication (7.22%).
PERBEDAAN TARIF INA–CBG’S DENGAN BIAYA RILL PASIEN PPOK DI RSU ANWAR MEDIKA SIDOARJO Silitonga, Esteria; Lorensia, Amelia; Jalmav, Marthy Meliana Ariyanti; Gitaputri, Putu Aprilya
CoMPHI Journal: Community Medicine and Public Health of Indonesia Journal Vol. 5 No. 1 (2024): Juni
Publisher : Perhimpunan Dokter Kedokteran Komunitas dan Kesehatan Masyarakat Indonesia (PDK3MI)

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Pasien dengan PPOK mengalami penurunan kapasitas kualitas hidup, ketidakmampuan fisik serta peningkatan biaya hidup. Tujuan penelitian ini mengetahui perbedaan antara biaya rill dan tarif INA-CBG’s pada pasien PPOK rawat inap di RSU Anwar Medika Sidoarjo. Penelitian ini dilakukan Penelitian ini merupakan salah satu evaluasi ekonomi kesehatan yang bersifat observasional dengan melakukan studi perbandingan atara dua alternative yang ada dengan menggunakan perspektif rumah sakit dan pengambilan data yang dilakukan secara retrospektif. Subjek penelitian yang memenuhi kriteria inklusi sebanyak 81 pasien. Kriteria inklusi meliputi pasien rawat inap serangan PPOK dengan data lengkap (identitas pasien, pasien terdaftar BPJS dan data keuangan selama pengobatan). Hasil pengolahan data dari bantuan program SPSS for windows versi 26 dengan uji Mann-Whitney didapatkan data bahwa nilai P sebesar 0,158 lebih besar di bandingkan dengan nilai alpha 0,05 (Nilai P > Nilai α). Dapat disimpulkan bahwa tidak terdapat perbedaan yang signifikan terkait total biaya medis langsung antara kelompok biaya Riil dan tarif INA-CBG’s. Saran pada penelitian ini di lakukannya pengambilan data secara prospektif saat itu juga untuk memastikan atau menyesuaikan data yang terdapat pada rekam medis sesuai dengan keadaan subjek/pasien tersebut dengan tetap mempertimbangkan jumlah sampel.